Serologic Surveillance for SARS-CoV-2 Infection among Wild Rodents, Europe.

Vincent Bourret Lara Dutra Hussein Alburkat Sanna Mäki Ella Lintunen Marine Wasniewski Ravi Kant Maciej Grzybek Vinaya Venkat Hayder Asad Julien Pradel Marie Bouilloud Herwig Leirs Valeria Carolina Colombo Vincent Sluydts Peter Stuart Andrew McManus Jana A Eccard Jasmin Firozpoor Christian Imholt Joanna Nowicka Aleksander Goll Nathan Ranc Guillaume Castel Nathalie Charbonnel Tarja Sironen

Abstract

We report results from serologic surveillance for exposure to SARS-CoV-2 among 1,237 wild rodents and small mammals across Europe. All samples were negative, with the possible exception of 1. Despite suspected potential for human-to-rodent spillover, no evidence of widespread SARS-CoV-2 circulation in rodent populations has been reported to date.Esitämme tulokset serologisesta tutkimuksesta, jossa seulottiin SARS-CoV-2 tartuntojen varalta 1,237 luonnonvaraista jyrsijää ja piennisäkästä eri puolilta Eurooppaa. Kaikki näytteet olivat negatiivisia, yhtä näytettä lukuun ottamatta. SARS-CoV-2:n läikkymisen ihmisistä jyrsijöihin on arveltu olevan mahdollista, mutta todisteet viruksen laajamittaisesta leviämisestä jyrsijäpopulaatioissa puuttuvat.

Supporting text Virus Host Location
coronavirus disease 15 COVID-19 467 Europe 28 respiratory infections 30 Rodentia 53 SARS-CoV-2 550 serologic tests 9 serosurveillance 2 severe acute respiratory infection coronavirus 2 1 viruses 117 zoonoses 477 COVID-19 425 Animals 1949 Antibodies, Viral 212 Europe 27 Humans 1441 Rodentia 51 SARS-CoV-2 453

Evidence records

1 total
Zoonotic Surveillance
1 records · 1 evidence types
Evidence type
1 records
OVE6500
Key finding

Serologic surveillance of 1,237 wild rodents and small mammals across Europe found no detectable antibodies to SARS-CoV-2, except possibly one sample.

Virus
Host
Location
Not specified
Supporting text

We report results from serologic surveillance for exposure to SARS-CoV-2 among 1,237 wild rodents and small mammals across Europe. All samples were negative, with the possible exception of 1.

Method
serologic surveillance | antibody testing
Sample type
serum samples